Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Ritchie

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Medical Economics|October 30, 2015
Master challenges by maximizing efficiencyElaine Pofeldt, Jeffrey Bendix, Donna Marbury, et al.
Anticancer Research|December 12, 2003
Activity profile of the novel aziridinylbenzoquinones MeDZQ and RH1 in human tumour xenograftsJeffrey Cummings, Alison Ritchie, John Butler, et al.
Heliyon|April 16, 2024
Efficacy of aerobic and resistance exercises on cancer pain: A meta-analysis of randomised controlled trialsPhilip D Austin, Wei Lee, Daniel Sj Costa, et al.
Medical Economics|September 20, 2014
Risk vs. reward. How to make new payment models work for your practiceSalynn Boyles, Jeffrey Bendix, Donna Marbury, et al.
BMC Geriatrics|May 13, 2021
"A good death but there was all this tension around"- perspectives of residential managers on the experience of delivering end of life care for people living with dementiaJessica A L Borbasi, Allison Tong, Alison Ritchie, et al.
The Journal of Pathology|March 10, 2016
Altered ratios of pro- and anti-angiogenic VEGF-A variants and pericyte expression of DLL4 disrupt vascular maturation in infantile haemangiomaXi Ye, Yassir Abou-Rayyah, Joyce Bischoff, et al.
Clinical and Translational Science|November 4, 2024
Implementing sensor-based digital health technologies in clinical trials: Key considerations from the eCOA ConsortiumElena S Izmailova, Danielle Middleton, Reem Yunis, et al.
Neuro-Oncology Advances|September 9, 2020
Metabolism-based isolation of invasive glioblastoma cells with specific gene signatures and tumorigenic potentialStuart James Smith, Jonathan Rowlinson, Maria Estevez-Cebrero, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Structure-Based Design of a Potent, Selective, and Brain Penetrating PDE2 Inhibitor with Demonstrated Target EngagementPeter Buijnsters, Meri De Angelis, Xavier Langlois, et al.
Disease Models & Mechanisms|November 4, 2024
The role of mesenchymal cells in cholangiocarcinomaMireia Sueca-Comes, Elena Cristina Rusu, Jennifer C Ashworth, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Medical Economics|October 30, 2015
Master challenges by maximizing efficiencyElaine Pofeldt, Jeffrey Bendix, Donna Marbury, et al.
Anticancer Research|December 12, 2003
Activity profile of the novel aziridinylbenzoquinones MeDZQ and RH1 in human tumour xenograftsJeffrey Cummings, Alison Ritchie, John Butler, et al.
Heliyon|April 16, 2024
Efficacy of aerobic and resistance exercises on cancer pain: A meta-analysis of randomised controlled trialsPhilip D Austin, Wei Lee, Daniel Sj Costa, et al.
Medical Economics|September 20, 2014
Risk vs. reward. How to make new payment models work for your practiceSalynn Boyles, Jeffrey Bendix, Donna Marbury, et al.
BMC Geriatrics|May 13, 2021
"A good death but there was all this tension around"- perspectives of residential managers on the experience of delivering end of life care for people living with dementiaJessica A L Borbasi, Allison Tong, Alison Ritchie, et al.
The Journal of Pathology|March 10, 2016
Altered ratios of pro- and anti-angiogenic VEGF-A variants and pericyte expression of DLL4 disrupt vascular maturation in infantile haemangiomaXi Ye, Yassir Abou-Rayyah, Joyce Bischoff, et al.
Clinical and Translational Science|November 4, 2024
Implementing sensor-based digital health technologies in clinical trials: Key considerations from the eCOA ConsortiumElena S Izmailova, Danielle Middleton, Reem Yunis, et al.
Neuro-Oncology Advances|September 9, 2020
Metabolism-based isolation of invasive glioblastoma cells with specific gene signatures and tumorigenic potentialStuart James Smith, Jonathan Rowlinson, Maria Estevez-Cebrero, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Structure-Based Design of a Potent, Selective, and Brain Penetrating PDE2 Inhibitor with Demonstrated Target EngagementPeter Buijnsters, Meri De Angelis, Xavier Langlois, et al.
Disease Models & Mechanisms|November 4, 2024
The role of mesenchymal cells in cholangiocarcinomaMireia Sueca-Comes, Elena Cristina Rusu, Jennifer C Ashworth, et al.
Pageof 4